Joshua T. Mendell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joshua T. Mendell has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Erik A. Wentzel
Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
6 shared publications- Oliver A. Kent
Department of Pharmacology, adMare BioInnovations, Montreal, Quebec, Canada
5 shared publications - Hun-Way Hwang
Department of Pathology, University of Pittsburgh
4 shared publications Anirban Maitra
The McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
3 shared publications- Chi Van Dang
Graduate Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, USA
3 shared publications Raghu R. Chivukula
Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
3 shared publications
Latest Publications
- 1 January 2011
- Published by Springer Nature in Science-Business eXchange
- Vol. 4 (2) , 42
MicroRNA-143 (miR-143); miR-145
- 1 January 2011
- Published by Springer Nature in Science-Business eXchange
- Vol. 4 (2) , 42
MicroRNA-143 (miR-143); miR-145
- Open Access
- 15 December 2010
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 24 (24) , 2754-2759
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
Although activating mutations in RAS oncogenes are known to result in aberrant signaling through multiple pathways, the role of microRNAs (miRNAs) in the Ras oncogenic program remains poorly characterized. Here we demonstrate that Ras activation leads to repression of the miR-143/145 cluster in cells of human, murine, and zebrafish origin. Loss of miR-143/145 expression is observed frequently in KRAS mutant pancreatic cancers, and restoration of these miRNAs abrogates tumorigenesis. miR-143/145 down-regulation requires the Ras-responsive element-binding protein (RREB1), which represses the miR-143/145 promoter. Additionally, KRAS and RREB1 are targets of miR-143/miR-145, revealing a feed-forward mechanism that potentiates Ras signaling.
- 15 December 2010
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 24 (24) , 2754-2759
Open AccessRepression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
Although activating mutations in RAS oncogenes are known to result in aberrant signaling through multiple pathways, the role of microRNAs (miRNAs) in the Ras oncogenic program remains poorly characterized. Here we demonstrate that Ras activation leads to repression of the miR-143/145 cluster in cells of human, murine, and zebrafish origin. Loss of miR-143/145 expression is observed frequently in KRAS mutant pancreatic cancers, and restoration of these miRNAs abrogates tumorigenesis. miR-143/145 down-regulation requires the Ras-responsive element-binding protein (RREB1), which represses the miR-143/145 promoter. Additionally, KRAS and RREB1 are targets of miR-143/miR-145, revealing a feed-forward mechanism that potentiates Ras signaling.
- 1 June 2010
- Published by SAGE Publications in Genes & Cancer
- Vol. 1 (6) , 568-575
Myc: Maestro of MicroRNAs
Hyperactivity of the Myc oncogenic transcription factor dramatically reprograms gene expression to facilitate cellular proliferation and tumorigenesis. To elicit these effects, Myc coordinates the activation and repression of an extensive network of protein-coding genes and, as has recently been appreciated, noncoding RNAs including microRNAs (miRNAs). Consistent with their ability to potently influence cancer phenotypes, the regulation of miRNAs by Myc affects virtually all aspects of the Myc oncogenic program, including proliferation, survival, metabolism, angiogenesis, and metastasis. This review will summarize the current understanding of the mechanisms underlying Myc-dependent transcriptional and posttranscriptional control of miRNAs and the resultant effects on tumorigenesis. As miRNAs are integral nodes in the transcriptional network controlled by Myc, modulating their activity represents a promising new approach for cancer therapy.
- 1 June 2010
- Published by SAGE Publications in Genes & Cancer
- Vol. 1 (6) , 568-575
Myc: Maestro of MicroRNAs
Hyperactivity of the Myc oncogenic transcription factor dramatically reprograms gene expression to facilitate cellular proliferation and tumorigenesis. To elicit these effects, Myc coordinates the activation and repression of an extensive network of protein-coding genes and, as has recently been appreciated, noncoding RNAs including microRNAs (miRNAs). Consistent with their ability to potently influence cancer phenotypes, the regulation of miRNAs by Myc affects virtually all aspects of the Myc oncogenic program, including proliferation, survival, metabolism, angiogenesis, and metastasis. This review will summarize the current understanding of the mechanisms underlying Myc-dependent transcriptional and posttranscriptional control of miRNAs and the resultant effects on tumorigenesis. As miRNAs are integral nodes in the transcriptional network controlled by Myc, modulating their activity represents a promising new approach for cancer therapy.
- 1 November 2009
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 8 (21) , 2013-2024
A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells
International academic publisher with offices worldwide. Publishing more than 2,100 journals, over 4,000 new books each year, with a books backlist in excess of 60,000 specialist titles. We are one of the world’s leading publishers of scholarly journals, books, eBooks, textbooks and reference works
- 1 November 2009
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 8 (21) , 2013-2024
A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells
International academic publisher with offices worldwide. Publishing more than 2,100 journals, over 4,000 new books each year, with a books backlist in excess of 60,000 specialist titles. We are one of the world’s leading publishers of scholarly journals, books, eBooks, textbooks and reference works
- 1 July 2009
- Published by Springer Nature in Nature Genetics
- Vol. 41 (7) , 768-769
Tumors line up for a letdown.
MicroRNAs (miRNAs) and the pathways that regulate their expression have critical functions during normal development. A new study demonstrates that select cancer cells have appropriated one developmental mechanism of miRNA regulation, the inhibition of let-7 biogenesis by the Lin-28 and Lin-28B RNA binding proteins, to rid themselves of an antitumorigenic miRNA. The usurpation of highly conserved developmental pathways is a common occurrence in human malignancies. Often, our fundamental understanding of these pathways comes well before an appreciation that they contribute to disease and is frequently gained from genetic studies in model organisms such as worms and flies.
- 1 July 2009
- Published by Springer Nature in Nature Genetics
- Vol. 41 (7) , 768-769
Tumors line up for a letdown.
MicroRNAs (miRNAs) and the pathways that regulate their expression have critical functions during normal development. A new study demonstrates that select cancer cells have appropriated one developmental mechanism of miRNA regulation, the inhibition of let-7 biogenesis by the Lin-28 and Lin-28B RNA binding proteins, to rid themselves of an antitumorigenic miRNA. The usurpation of highly conserved developmental pathways is a common occurrence in human malignancies. Often, our fundamental understanding of these pathways comes well before an appreciation that they contribute to disease and is frequently gained from genetic studies in model organisms such as worms and flies.
- 28 April 2009
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (17) , 7016-7021
Cell–cell contact globally activates microRNA biogenesis
MicroRNAs (miRNAs) are 18- to 24-nt RNA molecules that regulate messenger RNAs (mRNAs). Posttranscriptional mechanisms regulate miRNA abundance during development as well as in cancer cells where miRNAs frequently exhibit dysregulated expression. The molecular mechanisms that govern the global efficiency of miRNA biogenesis in these settings remain incompletely understood, and experimental systems for the biochemical dissection of these pathways are currently lacking. Here, we demonstrate that miRNAs are subject to dynamic posttranscriptional regulation in widely used cell culture systems. As diverse mammalian and Drosophila cell lines are grown to increasing density, miRNA biogenesis is globally activated, leading to elevated mature miRNA levels and stronger repression of target constructs. This broad increase in miRNA abundance is associated with enhanced processing of miRNAs by Drosha and more efficient formation of RNA-induced silencing complexes. These findings uncover a critical parameter necessary for accurate analysis of miRNAs in cell culture settings, establish a tractable system for the study of regulated miRNA biogenesis, and may provide insight into mechanisms that influence miRNA expression in physiologic and pathophysiologic states.
- 28 April 2009
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (17) , 7016-7021
Cell–cell contact globally activates microRNA biogenesis
MicroRNAs (miRNAs) are 18- to 24-nt RNA molecules that regulate messenger RNAs (mRNAs). Posttranscriptional mechanisms regulate miRNA abundance during development as well as in cancer cells where miRNAs frequently exhibit dysregulated expression. The molecular mechanisms that govern the global efficiency of miRNA biogenesis in these settings remain incompletely understood, and experimental systems for the biochemical dissection of these pathways are currently lacking. Here, we demonstrate that miRNAs are subject to dynamic posttranscriptional regulation in widely used cell culture systems. As diverse mammalian and Drosophila cell lines are grown to increasing density, miRNA biogenesis is globally activated, leading to elevated mature miRNA levels and stronger repression of target constructs. This broad increase in miRNA abundance is associated with enhanced processing of miRNAs by Drosha and more efficient formation of RNA-induced silencing complexes. These findings uncover a critical parameter necessary for accurate analysis of miRNAs in cell culture settings, establish a tractable system for the study of regulated miRNA biogenesis, and may provide insight into mechanisms that influence miRNA expression in physiologic and pathophysiologic states.
- 3 March 2009
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (9) , 3384-3389
Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation
Direct control of microRNA (miRNA) expression by oncogenic and tumor suppressor networks results in frequent dysregulation of miRNAs in cancer cells and contributes to tumorigenesis. We previously demonstrated that activation of the c-Myc oncogenic transcription factor (Myc) broadly influences miRNA expression and in particular leads to widespread miRNA down-regulation. miRNA transcripts repressed by Myc include several with potent tumor suppressor activity such as miR-15a/16–1, miR-34a, and let-7 family members. In this study, we have investigated mechanisms downstream of Myc that contribute to miRNA repression. Consistent with transcriptional down-regulation, Myc activity results in the decreased abundance of multiple miRNA primary transcripts. Surprisingly, however, primary transcripts encoding several let-7 miRNAs are not reduced in the high Myc state, suggesting a posttranscriptional mechanism of repression. The Lin-28 and Lin-28B RNA binding proteins were recently demonstrated to negatively regulate let-7 biogenesis. We now show that Myc induces Lin-28B expression in multiple human and mouse tumor models. Chromatin immunoprecipitation and reporter assays reveal direct association of Myc with the Lin-28B promoter resulting in transcriptional transactivation. Moreover, we document that activation of Lin-28B is necessary and sufficient for Myc-mediated let-7 repression. Accordingly, Lin-28B loss-of-function significantly impairs Myc-dependent cellular proliferation. These findings highlight an important role for Lin-28B in Myc-driven cellular phenotypes and uncover an orchestration of transcriptional and posttranscriptional mechanisms in Myc-mediated reprogramming of miRNA expression.
- 3 March 2009
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (9) , 3384-3389
Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation
Direct control of microRNA (miRNA) expression by oncogenic and tumor suppressor networks results in frequent dysregulation of miRNAs in cancer cells and contributes to tumorigenesis. We previously demonstrated that activation of the c-Myc oncogenic transcription factor (Myc) broadly influences miRNA expression and in particular leads to widespread miRNA down-regulation. miRNA transcripts repressed by Myc include several with potent tumor suppressor activity such as miR-15a/16–1, miR-34a, and let-7 family members. In this study, we have investigated mechanisms downstream of Myc that contribute to miRNA repression. Consistent with transcriptional down-regulation, Myc activity results in the decreased abundance of multiple miRNA primary transcripts. Surprisingly, however, primary transcripts encoding several let-7 miRNAs are not reduced in the high Myc state, suggesting a posttranscriptional mechanism of repression. The Lin-28 and Lin-28B RNA binding proteins were recently demonstrated to negatively regulate let-7 biogenesis. We now show that Myc induces Lin-28B expression in multiple human and mouse tumor models. Chromatin immunoprecipitation and reporter assays reveal direct association of Myc with the Lin-28B promoter resulting in transcriptional transactivation. Moreover, we document that activation of Lin-28B is necessary and sufficient for Myc-mediated let-7 repression. Accordingly, Lin-28B loss-of-function significantly impairs Myc-dependent cellular proliferation. These findings highlight an important role for Lin-28B in Myc-driven cellular phenotypes and uncover an orchestration of transcriptional and posttranscriptional mechanisms in Myc-mediated reprogramming of miRNA expression.
- 1 October 2008
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 33 (10) , 474-481
Circular reasoning: microRNAs and cell-cycle control
- 1 October 2008
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 33 (10) , 474-481
Circular reasoning: microRNAs and cell-cycle control
- 15 August 2008
- Published by Taylor & Francis in Cell Cycle
- Vol. 7 (16) , 2493-2499
Functional integration of microRNAs into oncogenic and tumor suppressor pathways
A large body of evidence has documented abnormal microRNA (miRNA) expression patterns in diverse human malignancies. Given that miRNA expression is tightly regulated during development and cellular differentiation, aberrant miRNA expression in cancer cells is likely to be in part a consequence of the loss of normal cellular identity that accompanies malignant transformation. Nevertheless, it is now clear that miRNAs function as critical effectors of several canonical oncogenic and tumor suppressor pathways, including those controlled by Myc and p53. Gain- and loss-of-function of these factors in cancer cells contributes to miRNA dysregulation, directly influencing neoplastic phenotypes including cellular proliferation and apoptosis.
- 15 August 2008
- Published by Taylor & Francis in Cell Cycle
- Vol. 7 (16) , 2493-2499
Functional integration of microRNAs into oncogenic and tumor suppressor pathways
A large body of evidence has documented abnormal microRNA (miRNA) expression patterns in diverse human malignancies. Given that miRNA expression is tightly regulated during development and cellular differentiation, aberrant miRNA expression in cancer cells is likely to be in part a consequence of the loss of normal cellular identity that accompanies malignant transformation. Nevertheless, it is now clear that miRNAs function as critical effectors of several canonical oncogenic and tumor suppressor pathways, including those controlled by Myc and p53. Gain- and loss-of-function of these factors in cancer cells contributes to miRNA dysregulation, directly influencing neoplastic phenotypes including cellular proliferation and apoptosis.